www.neurologiepropraxi.cz / Neurol. praxi. 2025;26(3):240-243 / NEUROLOGIE PRO PRAXI 243 Z POMEZÍ NEUROLOGIE Úzkostné poruchy pri epilepsii epilepsy. Epilepsy Behav. 2016;59:87-91. doi:10.1016/j.yebeh.2016.03.020. 5. Brandt C, Schoendienst M, Trentowska M, et al. Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders – results of an open- -label, parallel group, investigator-initiated, proof-of-concept study. Epilepsy Behav. 2013;29:298-304. doi:10.1016/j.yebeh.2013.08.004. 6. Campbell C, Cavalleri GL, Delanty N. Exploring the genetic overlap between psychiatric illness and epilepsy: a review. Epilepsy & Behavior. 2020;102:106669. 7. Fiest KM, Patten SB, Jetté N. Screening for depression and anxiety in epilepsy. Neurol Clin. 2016;34(2):351-361. doi:10.1016/j.ncl.2015.11.003. 8. Gomez-Arias B, Crail-Melendez D, Lopez-Zapata R, et al. Severity of anxiety and depression are related to a higher perception of adverse effects of antiepileptic drugs. Seizure. 2012;21:588-594. doi:10.1016/j.seizure.2012.06.003. 9. Guo Y, Ding XY, Lu RY, et al. Depression and anxiety are associated with reduced antiepileptic drug adherence in Chinese patients. Epilepsy Behav. 2015;50:91-95. doi:10.1016/j. yebeh.2015.06.042. 10. Hagemann A, May TW, Nieder E, et al. Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy. Epilepsy Res. 2013;104:140-150. doi:10.1016/j.eplepsyres.2012.08.005. 11. Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006;59:35-41. doi:10.1016/j.eplepsyres.2007.05.001. 12. Jacoby A, Snape D, Lane S, et al. Self-reported anxiety and sleep problems in people with epilepsy and their association with quality of life. Epilepsy Behav. 2015;43:149-158. doi:10.1016/j.yebeh.2014.09.071. 13. Jarčušková D, Palušná M, Gazda J, et al. Which clinical and neuropsychological factors are responsible for cognitive impairment in patients with epilepsy? Int J Public Health. 2020;65(6):947-956. doi:10.1007/s00038-020-01401-7. 14. Kanner AM. Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 2009;15:83-87. doi:10.1016/j.yebeh.2009.02.034. 15. Mensah SA, Beavis JM, Thapar AK, et al. A community study of the presence of anxiety disorder in people with epilepsy. Epilepsy Behav. 2007;11(1):118-124. doi:10.1016/j.yebeh.2007.04.012. 16. Meyer B, Weiss M, Holtkamp M, et al. Effects of an epilepsy-specific Internet intervention (Emyna) on depression: results of the ENCODE randomized controlled trial. Epilepsia. 2019;60(4):656-668. doi:10.1111/epi.14673. 17. Mula M. Treatment of anxiety disorders in epilepsy: an evidence-based approach. Epilepsia. 2013;54(1):13-18. doi:10.1111/ epi.12101. 18. Mula M, Pini S, Cassano GB. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol. 2007;27:263-272. doi:10.1097/ jcp.0b013e318059361a. 19. Niu C, Li P, Du X, et al. Risk factors for anxiety in patients with epilepsy: A meta-analysis. Epilepsy Behav. 2024;153:109665. doi:10.1016/j.yebeh.2024.109665. 20. Parkerson HA, Thibodeau MA, Brandt CP, et al. Cultural- -based biases of the GAD-7. J Anxiety Disord. 2015;31:38-42. doi:10.1016/j.janxdis.2015.01.005. 21. Penninx BW, Pine DS, Holmes EA, et al. Anxiety disorders. Lancet. 2021;397(10277):914-927. doi:10.1016/S01406736(21)00359-7. 22. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med. 2004;10:685-692. doi:10.1038/nm1074. 23. Salpekar JA, Ma GJ, Mietchen J, Mani J, Jones JE. Treatment of Comorbid Anxiety and Epilepsy. J Neuropsychiatry Clin Neurosci. 2023;35(3):218-227. doi: 10.1176/appi.neuropsych.20220116. Epub 2023 Feb 14. PMID: 36785943. 24. Seo JG, Cho YW, Lee SJ, et al. Validation of the Generalized Anxiety Disorder-7 in people with epilepsy: a MEPSY study. Epilepsy Behav. 2014;35:59-63. doi:10.1016/j.yebeh.2014.04.005. 25. Sirven JI, Schachter SC.Seizure Medications and Mood. Epilepsy Foundation. 2022. [Internet 1. 9. 2024]. Available from: https://www.epilepsy.com/complications-risks/moods-behavior/medications. 26. Stahl SM. Brainstorms: symptoms and circuits, part 2: anxiety disorders. J Clin Psychiatry. 2003;64:1408-1409. doi:10.4088/ jcp.v64n1201. 27. Stern AF. The Hospital Anxiety and Depression Scale. Occup Med. 2014;67(6):361. doi:10.1093/occmed/kqu024. 28. Šlepecký M, Praško J, Grendelová M, Jandová K. Komplexný manažment adolescentného a dospelého pacienta s generalizovanou úzkostnou poruchou. [Internet 1. 9. 2024]. Available from: https://health.gov.sk/Zdroje?/Sources/dokumenty/SDTP/standardy/1-6-2020/098_KP_Komplexny_manazment_adolescentneho_a_dospeleho_pacienta_s_generalizovanou_uzkostnou_poruchou.pdf. 29. Teixeira AL. Peri-Ictal and Para-Ictal Psychiatric Phenomena: A Relatively Common Yet Unrecognized Disorder. Curr Top Behav Neurosci. 2022;55:171-181. doi: 10.1007/7854_2021_223. PMID: 33728598. 30. Vinti V, Dell'Isola GB, Tascini G, et al. Temporal Lobe Epilepsy and Psychiatric Comorbidity. Front Neurol. 2021;12:775781. doi: 10.3389/fneur.2021.775781. NEUROLOGIE PRO PRAXI / Neurol. praxi. 2025;26(2):??? Neurologie pro praxi vyhlašuje soutěž na rok 2025 o nejlepší sdělení z praxe publikované v časopise Neurologie pro praxi CENA ARNOLDA PICKA Redakční rada časopisu Neurologie pro praxi vyhlásila soutěž o nejlepší prakticky orientovanou práci nebo příspěvek z praxe (kazuistiku, videokazuistiku) publikovaný v roce 2025 na stránkách časopisu Neurologie pro praxi. Všechny práce publikované v časopise Neurologie pro praxi v roce 2025 budou do soutěže zahrnuty automaticky. Práce vyhodnotí redakční rada, která tajným hlasováním rozhodne o vítězné publikaci. Cena Arnolda Picka za rok 2025 bude předána na 23. sympoziu praktické neurologie (Brno, 11.–12. června 2026) Více informací o sympoziu na www.kongresneurologie.cz
RkJQdWJsaXNoZXIy NDA4Mjc=